Review: could Keppra cause Disseminated intravascular coagulation?
Summary: Disseminated intravascular coagulation is found among people who take Keppra, especially for people who are female, 30-39 old, have been taking the drug for < 1 month, also take medication Lamictal, and have Epilepsy.
We study 19,909 people who have side effects while taking Keppra from FDA and social media. Among them, 29 have Disseminated intravascular coagulation. Find out below who they are, when they have Disseminated intravascular coagulation and more.
You are not alone: join a mobile support group for people who take Keppra and have Disseminated intravascular coagulation >>>
Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from 21,243 Keppra users)
Disseminated intravascular coagulation
Disseminated Intravascular Coagulation (systemic activation of blood coagulation) has been reported by people with rheumatoid arthritis, preventive health care, high blood pressure, pain, infection. (latest reports from 14,200 Disseminated Intravascular Coagulation patients)
On Jan, 31, 2015: 19,901 people reported to have side effects when taking Keppra. Among them, 29 people (0.15%) have Disseminated Intravascular Coagulation.
Time on Keppra when people have Disseminated intravascular coagulation * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Disseminated intravascular coagulation||44.44%||22.22%||22.22%||11.11%||0.00%||0.00%||0.00% |
Gender of people who have Disseminated intravascular coagulation when taking Keppra * :
|Disseminated intravascular coagulation||52.94%||47.06% |
Age of people who have Disseminated intravascular coagulation when taking Keppra * :
|Disseminated intravascular coagulation||0.00%||3.57%||3.57%||21.43%||35.71%||7.14%||10.71%||17.86% |
Severity of Disseminated intravascular coagulation when taking Keppra ** :
How people recovered from Disseminated intravascular coagulation ** :
Top conditions involved for these people * :
- Epilepsy (14 people, 48.28%)
- Depression (7 people, 24.14%)
- Convulsion (4 people, 13.79%)
- Acute promyelocytic leukaemia (3 people, 10.34%)
- Pulmonary embolism (3 people, 10.34%)
Top co-used drugs for these people * :
- Lamictal (13 people, 44.83%)
- Protonix (7 people, 24.14%)
- Celexa (6 people, 20.69%)
- Ibuprofen (6 people, 20.69%)
- Tegretol (5 people, 17.24%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Disseminated Intravascular Coagulation while taking Keppra?
You are not alone! Join a mobile support group on :
- support group for people who take Keppra and have Disseminated Intravascular Coagulation
- support group for people who take Keppra
- support group for people who have Disseminated intravascular coagulation
Drugs in real world that are associated with:
Could your condition cause:
Recent Keppra related drug comparison:
- Comparions of Levothyroxine Sodium, Omeprazole, Keppra for a 68-year old woman who has Confusion, Barrett's Esophagus
- Comparions of Keppra, Depakote, Mysoline for a 56-year old man who has Focal Epilepsy
- Comparions of Lamictal, Keppra for a 57-year old woman who has Epilepsy
- Comparions of Depakote Er, Keppra, Lamictal for a 50-year old woman who has Epilepsy
- Comparions of Keppra, Ritalin, Lyrica for a 35-year old woman who has Cavernous Hemangioma
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.